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Epidermal and hair follicle development from surface
ectodermal progenitor cells requires coordinated
changes in gene expression. Histone deacetylases
alter gene expression programs through modifica-
tion of chromatin and transcription factors. We find
that deletion of ectodermal Hdac1 and Hdac2 results
in dramatic failure of hair follicle specification and
epidermal proliferation and stratification, phenoco-
pying loss of the key ectodermal transcription factor
p63. Although expression of p63 and its positively
regulated basal cell targets is maintained in Hdac1/
2-deficient ectoderm, targets of p63-mediated re-
pression, including p21, 14-3-3s, and p16/INK4a,
are ectopically expressed, and HDACs bind and
are active at their promoter regions in normal undif-
ferentiated keratinocytes. Mutant embryos display
increased levels of acetylated p53, which opposes
p63 functions, and p53 is required for HDAC inhib-
itor-mediated p21 expression in keratinocytes. Our
data identify critical requirements for HDAC1/2 in
epidermal development and indicate that HDAC1/2
directly mediate repressive functions of p63 and
suppress p53 activity.
INTRODUCTION
The development of complex tissues from embryonic progenitor
cells requires imposition of coordinated changes in gene
expression programs. Conversely, development of malignancies
involves broad suppression of differentiation programs and
reversion to a more embryonic-like state. The accessibility and
well-studied biology of the epidermis, and the prevalence of
skin cancers, make it an ideal and important system in which
to study these processes.DevelopmeIn mouse embryos, epidermal differentiation begins at approx-
imately E8.5, when the single-layered ectoderm begins to
express simple epithelial keratins KRT8 and 18, and the
epidermal lineage-determining transcription factor p63 (Koster
et al., 2007). Expression of basal cell keratins KRT5 and KRT14
is initiated at E9.5 (Byrne et al., 1994). Starting at E12.5, asym-
metric cell divisions perpendicular to the plane of the epidermis
are occasionally observed and are associated with the begin-
nings of epidermal stratification (Lechler and Fuchs, 2005). By
birth the epidermis is composed of basal, suprabasal, granular
and outer cornified layers, and forms a functional barrier that is
essential for postnatal survival. Terminally differentiated corni-
fied cells are continuously shed and replenished through the
mitotic activity of basal progenitor cells that both self-renew
and give rise to suprabasal progeny that enter the stratification
program. Although most embryonic surface ectodermal cells
undergo epidermal stratification, a subset of these cells interacts
with the underlying mesenchyme to form a variety of ectodermal
appendage organs (Mikkola and Millar, 2006).
p63 is essential for ectodermal appendage specification,
epidermal proliferation and asymmetric cell division, and epi-
dermal development, acting upstream of other early regulators
of these processes (Koster, 2010; Laurikkala et al., 2006; Lechler
and Fuchs, 2005; Mills et al., 1999; Truong and Khavari, 2007;
Yang et al., 1999). Studies of p63 mutant thymus in vivo, and
clonogenic assays in keratinocytes, support a key role for p63
in maintaining the proliferative potential of stem cells in stratified
epithelia (Senoo et al., 2007).
Two classes of p63 isoforms are transcribed, TAp63 and
DNp63, that respectively contain or lack an N-terminal transacti-
vating domain. Each class includes multiple splice variants
with differing activities, complicating mechanistic analysis
(Blanpain and Fuchs, 2007). The predominant p63 isoform in
embryonic epidermis, DNp63a, can function as either an acti-
vator or a repressor, depending on the target gene (McDade
and McCance, 2010). DNp63a regulates the proliferation of
epidermal progenitor cells by directly repressing expression of
anti-proliferative target genes, such as 14-3-3s and p21 (Westfall
et al., 2003; Truong et al., 2006). DNp63a also directly repressesntal Cell 19, 807–818, December 14, 2010 ª2010 Elsevier Inc. 807
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and defects in proliferation, epidermal stratification and ecto-
dermal appendage development are partially rescued in p63
mutants by concomitant loss of p16/Ink4a or, to a lesser extent,
by loss of p19/Arf (Su et al., 2009). In addition to its repressive
functions, DNp63a directly activates genes important for
epidermal differentiation, including Krt14, Ikka, Fasn, Claudin1,
and Gata3 (Chikh et al., 2007; Koster et al., 2007; Lopardo
et al., 2008; Marinari et al., 2009; Romano et al., 2009). In vitro
experiments suggest that p63 acts in opposition to the related
transcription factor p53 in regulating epidermal proliferation but
controls differentiation by a separate, p53-independent mecha-
nism (Truong et al., 2006).
Lineage-determining transcription factors generally act in
concert with chromatin regulators that permit access to
sequence-specific binding sites and allow inheritance of gene
expression programs (Kim et al., 1999). However, interactions
of p63 with chromatin-modifying factors have yet to be
described. Genetic analyses in the mouse, and experiments in
organotypic culture, have revealed requirements for the histone
methylase EZH2, and the DNA methyltransferase DNMT1,
respectively, in maintaining epidermal progenitor cell prolifera-
tion (Ezhkova et al., 2009; Sen et al., 2010), but loss of these
factors is associatedwith premature differentiation of basal cells,
a phenotype distinct from that observed in p63 null embryos.
Histone deacetylases (HDACs) remove histone acetylation
marks, resulting in compaction of chromatin structure and tran-
scriptional repression (Ruthenburg et al., 2007). HDACs operate
by direct association with DNA-binding factors and by incorpo-
ration into large multifunctional repressor complexes such as
Sin3, NuRD, coREST, and PRC2 (Brunmeir et al., 2009). In addi-
tion to functions in chromatin remodeling, HDACs deacetylate
certain transcription factors, such as p53, resulting in their
decreased activity (Higashitsuji et al., 2007; Tang et al., 2008).
HDACs form a large family, of which class I HDACs, including
the closely related proteins HDAC1 and HDAC2, show the stron-
gest histone deacetylase activity (Haberland et al., 2009).
Although HDAC1 and HDAC2 perform nonredundant roles in
early development, these proteins coexist in repressive
complexes, and tissue-specific deletion at later developmental
stages reveals redundant functions for Hdac1 and Hdac2 in
multiple different cell types (Brunmeir et al., 2009).
Several lines of evidence suggest important roles for histone
deacetylation in epidermal development. Epidermal-specific
deletion of Mi-2b, encoding an ATP-dependent chromatin-
remodeling enzyme associated with HDAC1 and 2 in the NuRD
complex, results in failure of hair follicle specification and gradual
loss of basal epidermal progenitor cells (Kashiwagi et al., 2007).
Class I and II HDACs also associate with the chromatin-remod-
eling ATPase BRG1, which is required for keratinocyte terminal
differentiation (Indra et al., 2005). Treatment of adult skin with
the HDAC inhibitor trichostatin A (TSA) causes hair follicle stem
cells to proliferate and exit the stem cell compartment (Frye
et al., 2007). However, the precise functions of specific HDAC
isoforms in the epidermis in vivo have not been elucidated, and
their requirements for embryonic epidermal development are
unknown.
Here, we show that HDAC1 and HDAC2 are expressed in
a dynamic and overlapping fashion in developing skin and hair808 Developmental Cell 19, 807–818, December 14, 2010 ª2010 Elsfollicles. Deletion of both genes in the epidermis results in
a phenotype that strikingly resembles that of p63 null skin, and
derepression of negatively regulated DNp63 target genes, in-
cluding the senescence factor p16/Ink4a. HDAC1/2 are present
at the promoter regions of DNp63-repressed targets in keratino-
cytes, and histones in these regions are hyperacetylated
following HDAC inhibition, indicating a direct requirement for
HDAC1/2 in DNp63-mediated repression. In addition, p53 is
hyperacetylated in Hdac1/2mutant epidermis, and experiments
in keratinocytes indicate that increased p53 function contributes
to the anti-proliferative effects of Hdac1/2 deletion via induction
of p21 expression. These data reveal redundant and essential
roles for Hdac1/2 in controlling the activities of key regulators
of epidermal development.
RESULTS
HDAC1 and HDAC2 Are Expressed in Dynamic
and Overlapping Patterns in Developing Skin
Analysis of HDAC1 and HDAC2 expression in epidermal devel-
opment revealed homogeneous expression of both proteins in
epidermal nuclei at E13, prior to stratification of the epidermis
(Figures 1A and 1B). At later developmental stages, HDAC1
and HDAC2 were expressed in all epidermal cells but localized
most strongly to nuclei in outer, differentiating cell layers (Figures
1C–1J) and in the leading edges of developing hair follicles
(Figures 1E and 1F).
Tissue-Specific Deletion of EitherHdac1 orHdac2Alone
Does Not Impact Epidermal Development or
Homeostasis
To delineate the functional requirements forHdac1 andHdac2 in
epidermal development, we utilized KRT14-Cre transgenic mice
in which Cre recombinase is efficiently expressed prior to hair
follicle development or epidermal stratification (Liu et al., 2007),
in combination with conditional loss of function alleles of either
Hdac1 or Hdac2 (Montgomery et al., 2007). Consistent with the
phenotypes of previously described tissue-specific Hdac1 or
Hdac2 single mutants (Haberland et al., 2009), KRT14-Cre
Hdac1fl/fl and KRT14-Hdac2fl/fl mice were viable and fertile and
displayed no gross or histological skin abnormalities. Similarly,
compound heterozygous, KRT14-Cre Hdac1fl/fl Hdac2fl/+, and
KRT14-Cre Hdac1fl/+ Hdac2fl/fl mice showed no gross or histo-
logical defects in epidermal or hair follicle development or
homeostasis (see Figure S1 available online; data not shown).
Hdac1/2 Epidermal Mutants Display Multiple,
Severe Ectodermal Defects
To determine whether loss of both Hdac1 and Hdac2 resulted in
epidermal abnormalities, we generated KRT14-Cre Hdac1fl/fl
Hdac2fl/fl (DcKO) mice that lacked all four functional alleles in
the epidermis. DcKO mice died perinatally with multiple and
dramatic ectodermal defects (Figure 2). Immunostaining of
DcKO-mutant skin revealed absence of both HDAC1 and
HDAC2 proteins in surface epithelia by E14.5 (Figures 2A–2F).
Consistent with key functions of HDAC1/2 in histone deacetyla-
tion, levels of histone H3 acetylated at lysine 9 (H3K9Ac) were
markedly increased in E14.5 DcKO compared with control litter-
mate epidermis (Figures 2G and 2H).evier Inc.
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Figure 1. HDAC1 and HDAC2 Display Overlapping, Dynamic Expres-
sion in Developing Epidermis and Hair Follicles
Immunohistochemistry (brown) for HDAC1 and HDAC2 at the stages indi-
cated.
(A and B) HDAC1 and HDAC2 are expressed in all cells of the E13 single-layer
epidermis.
(C and D) HDAC1 and HDAC2 are ubiquitously expressed in E14.5 epidermis
and hair follicle placodes (arrows).
(E and F) HDAC1 and HDAC2 are expressed most strongly at the leading edge
of E16.5 hair follicles (black arrows) and in differentiating epidermal cells (blue
arrows).
(G–J) At E18.5, HDAC1 and HDAC2 are expressed strongly in differentiating
epidermal cells (blue arrows). Dashed-black lines indicate dermal-epidermal
junctions. Scale bar in (J) applies to all images.
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fusion, and failure of limb-digit separation (Figures 2I and 2J).
Histological analysis showed that, instead of stratifying, the
epidermis remained as a single layer throughout embryogenesis
and lacked any signs of hair follicle development (Figures
2K–2P). Tooth development was initiated, consistent with the
early timing of this process relative to KRT14-Cre activity (Liu
et al., 2008); however, dental structures were abnormal in
DcKO mutants at E16.5 (Figures 2Q and 2R) and degraded by
E18.5 (Figures 2S and 2T). Formation of keratinized filiform
papillae in tongue epithelium was absent in DcKO mutants,
and like the epidermis, tongue surface ectoderm remained as
a single layer throughout embryogenesis (Figures 2U and 2V).
Histological analysis of DcKO embryonic limbs revealed failureDevelopmeof epidermal differentiation between the digits that is required
for digit separation (e.g., Ingraham et al., 2006) (Figures 2W
and 2X), and analysis of mutant eyes at E18.5 showed that eyelid
development was arrested (Figure S2).
Hdac1/2 Are Required for Suprabasal Epidermal
Differentiation and Initiation of Hair Follicle
Development
To dissect the molecular basis for the abnormalities observed in
DcKO embryos, we first examined the expression of molecular
markers for epidermal stratification. The basal cell keratin,
KRT14, was expressed similarly in control and DcKO epidermis
at E14.5. At later embryonic stages, KRT14 was confined to
basal cells in controls and remained expressed in the ectoderm
of DcKO embryos. By contrast, KRT10, which marks suprabasal
cells in control embryos from approximately E15, was not
expressed in DcKO epidermis at any stage. Loricrin, a marker
for the granular layer, was readily detected in control embryos
at E16.5 but was not expressed at any stage in DcKO embryos
(Figure 3A). To determine whether epidermal cells revert to
a less-differentiated state in DcKO mutants, we asked whether
the simple epithelial keratin, KRT18, is ectopically expressed.
Immunostaining at E16.5 revealed absence of KRT18 expression
in both control and DcKO epidermis (Figures S3A and S3B).
Thus, basal epidermal development is initiated and maintained
in DcKO embryos, but differentiation and stratification of the
epidermis completely fail.
Like epidermal stratification, initiation of hair follicle develop-
ment requires a global switch in the program of ectodermal
differentiation. To determine the stage at which hair follicle
development is blocked in DcKO mutants, we carried out whole
mount in situ hybridization for Ctnnb1 (encoding b-catenin),
a very early marker for hair follicle placode initiation (Zhang
et al., 2009). Patterned expression of Ctnnb1, corresponding to
hair follicle pre-placodes, was observed in control epidermis at
E14.0 but was absent in DcKO mutants, indicating that placode
development was not initiated (Figure 3B). Similarly, nuclear
b-catenin protein and its transcriptional partner LEF1 were
elevated in control hair follicle placodes and downregulated
in intervening epidermis at E14.5 (Jamora et al., 2003; Zhang
et al., 2009), whereas DcKO epidermis displayed uniform, low-
level expression of nuclear b-catenin and LEF1 (Figure 3C).
Vibrissa and mammary placode formation is initiated prior to
efficient expression of KRT14-Cre (Liu et al., 2007). Elevated
Ctnnb1 expression marked developing vibrissae and mammary
buds in DcKO as well as control embryos (Figures S3C and
S3D). These observations indicate that Hdac1/2 are not required
to maintain elevated Ctnnb1 expression but, rather, are neces-
sary to allow hair follicle fate acquisition. Thus, Hdac1/2 are
required for at least two different types of developmental transi-
tion in embryonic surface ectoderm: stratification and hair follicle
initiation.
DcKO Embryos Display Progressive Defects
in Proliferation and Apoptosis
To determine whether proliferation was affected by Hdac1/2
deletion, we analyzed the percentage of phospho-histone H3
(PH3)-positive basal cells in mutant and control littermate
epidermis. At E14.5, proliferation was decreased in DcKOntal Cell 19, 807–818, December 14, 2010 ª2010 Elsevier Inc. 809
Figure 2. Embryos Lacking Epidermal HDAC1 and HDAC2 Display Striking Defects in Epidermal and Ectodermal Appendage Development
(A–F) Immunofluorescence (green) reveals expression of HDAC1 and HDAC2 in the epidermis and developing hair follicles of control E14.5 and E16.5 Hdac1fl/fl
Hdac2fl/fl littermate skin (A, C, and E) and their absence in KRT14-Cre Hdac1fl/fl Hdac2fl/fl (DcKO) epidermis (B, D, and F) (arrows).
(G and H) Immunofluorescence (green) reveals increased levels of H3K9Ac in DcKO (H) compared with control (G) epidermis (arrows).
(I and J) Open eyes, thin smooth skin, and failure of digit septation in a DcKO embryo at E18.5 (J) compared with a control KRT14-Cre Hdacfl/+ Hdac2fl/fl littermate
(I) (arrows). (K–X) Hematoxylin and eosin staining reveals defects in stratification and ectodermal appendage development in DcKO compared with control litter-
mate embryos.
(K and L) Absence of hair follicle placodes in E14.5 DcKO epidermis (L) compared with control skin (K, arrow).
(M–P) DcKO epidermis remains as a single-cell layer at E16.5 (M and N) and E18.5 (O and P) instead of stratifying, and lacks hair follicles.
(Q–T) Abnormal DcKO dental lamina morphology at E16.5 (Q and R, arrows) and degeneration of incisor (black arrows) and molar (blue arrows) dental structures
at E18.5 (S and T).
(U and V) Failure of filiform papilla morphogenesis in E18.5 DcKO tongue surface ectoderm (arrows).
(W and X) Sections through E18.5 hindlimbs reveal digit formation and failure of epidermal differentiation between the digits in the DcKO (arrows).
Nuclei in (A)–(H) are DAPI stained (blue). Dashed lines mark dermal-epidermal borders. Scale bar in (F) applies to (A)–(F), scale bar in (H) applies to (G) and (H),
scale bar in (P) applies to (K)–(P), and scale bars in (R), (T), (V), and (X) also apply to their respective littermate controls.
See also Figures S1 and S2.
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(20 fields of view counted at 403 magnification for each geno-
type; p < 1 3 104). By E16.5 this percentage had decreased
to only 17% of control levels (p < 1 3 105) (Figures 3D and
3F; see also Figures S3E–S3H). The progressive nature of this810 Developmental Cell 19, 807–818, December 14, 2010 ª2010 Elsproliferation defect is consistent with failure of self-renewal of
progenitor cells (Sen et al., 2010; Senoo et al., 2007).
To determine whether programmed cell death contributed to
the Hdac1/2 mutant phenotype, we utilized a TUNEL assay.
Interestingly, there was no statistically significant difference inevier Inc.
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Figure 3. Loss of Epidermal Hdac1/2 Causes Failure of Epidermal Stratification, Absence of Hair Follicle Specification, and Progressive
Defects in Proliferation and Cell Survival
(A) Immunofluorescence (red) with antibodies to the basal layer marker KRT14, the suprabasal marker KRT10, and the granular layer marker loricrin reveals
expression of KRT14 but lack of KRT10 and loricrin in DcKO epidermis at E14.5–E18.5. The weak signal in E16.5 DcKO skin incubated with anti-KRT10 is
due to background fluorescence in the periderm.
(B) Whole mount in situ hybridization (blue-purple) for Ctnnb1 reveals formation of hair follicle pre-placodes in E14.0 control littermate skin (arrows) and their
absence in DcKO skin.
(C) Immunohistochemistry for b-catenin (brown) and immunofluorescence for LEF1 (green) reveal upregulated expression in developing hair follicle placodes
(black or white arrows) and lower or absent expression in inter-placodal epidermis (blue or yellow arrows) in controls, and uniform low-level expression in
DcKO epidermis (black or white arrows).
(D) Immunofluorescence for PH3 (green) reveals decreased proliferation in DcKO epidermis at E14.5 and almost absent proliferation at E16.5 (arrows). E16.5
samples were costained with anti-KRT14 (red) to mark basal cells.
(E) TUNEL staining (green) reveals increased cell death in DcKO embryos at E16.5 (arrows) but not at E14.5 compared to littermate controls.
(F) Quantification of the percentage of PH3-positive basal layer cells reveals a statistically significant decrease in proliferation in DcKO compared with control
embryos at E14.5 and a further decrease in the relative rate of proliferation at E16.5. Twenty fields of view were counted for each genotype.
(G) Quantification of the number of TUNEL-positive cells per field of view at 403magnification reveals a statistically significant increase in the number of apoptotic
basal cells in DcKO embryos at E16.5, but not at E14.5. Twenty fields of view were counted for each genotype.
Statistical data are represented as mean values; error bars indicate SEM. Dashed lines indicate dermal-epidermal junctions. NS, not statistically significant.
See also Figure S3.
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epidermis at E14.5 (20 fields of view counted at 403 magnifica-
tion for each genotype; p = 0.32), indicating that the initial defects
observed in DcKO skin were not due to increased apoptosis.
However, by E16.5 an approximately 6-fold increase in the rate
of basal cell apoptosis was observed in DcKO compared with
control epidermis (p < 0.4 3 105) (Figures 3E and 3G).DevelopmeHdac1/2 Are Not Required for Maintaining Expression of
DNp63 and Its Positively Regulated Basal Cell Targets
The ectodermal defects observed in DcKO embryos were
strikingly reminiscent of many of the phenotypes described
in embryos lacking p63, including lack of epidermal stratifica-
tion, decreased proliferation, failure of hair follicle specification,
defective eyelid development, absence of tongue filiformntal Cell 19, 807–818, December 14, 2010 ª2010 Elsevier Inc. 811
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Hdac1/2 Are Required for Epidermal Developmentpapillae, and defective dental development (Laurikkala et al.,
2006; Lechler and Fuchs, 2005; Mills et al., 1999; Yang et al.,
1999). Of particular note, similar to p63 null skin, Hdac1/2 defi-
cient embryonic epidermis exhibited failure of proliferation in
the absence of premature differentiation.
Therefore, we asked whether expression of p63 is maintained
following deletion of Hdac1/2. Immunostaining using an anti-
body that recognizes all p63 isoforms revealed expression of
p63 in basal cells and in some immediately suprabasal cells in
control embryos at E14.5–E18.5. In DcKO embryos, strong
expression of p63 was observed in the epidermis at E14.5 and
was maintained at E16.5 and E18.5 (Figure 4A). To determine
whether similar p63 isoforms were expressed in control and
DcKO skin, we used antibodies specific for DNp63 and TAp63
isoform classes (Romano et al., 2009).DNp63 isoforms predomi-
nated in both control and DcKO epidermis at E14.5 (Figures 4B
and 4C). As previously reported, TAp63 isoforms were not de-
tected in control skin at this stage (Laurikkala et al., 2006;
Romano et al., 2009) and were also not detectable in the mutant
(Figures 4D and 4E).
Because p63 isoform expression appeared unchanged by
deletion of Hdac1/2, we asked whether Hdac1/2 might mediate
p63 function. Positively regulated targets of DNp63 in epidermal
basal cells include Krt14 (Romano et al., 2009), fatty acid syn-
thase (Fasn) (Lefkimmiatis et al., 2009), the cell cycle progression
regulator Cdc25c (Lefkimmiatis et al., 2009), claudin1 (Lopardo
et al., 2008), and Ikka (Candi et al., 2006; Marinari et al., 2009).
As shown in Figure 3A, maintenance of KRT14 expression was
unaffected by Hdac1/2 deletion. Similarly, FASN, CDC25, Clau-
din1, and IKKa were expressed in DcKO epidermis (Figures 4F–
4K; Figures S4A–S4D). Consistent with absence of stratification,
GATA3, a positively regulated target of TAp63 in suprabasal cells
(Chikh et al., 2007), was not expressed in DcKO epidermis
(Figures S4E and S4F).
DNp63-Repressed Targets Are Upregulated
in Hdac1/2-Deficient Epidermis
Because expression of positively regulated basal cell DNp63
targets was unaffected by Hdac1/2 deletion, we next examined
expression of 14-3-3s and p21, which are direct targets of
DNp63-mediated repression (Westfall et al., 2003). In control
epidermis at E14.5, 14-3-3s was expressed in emerging supra-
basal layers but was largely absent from the basal layer.
However, E14.5 DcKO embryos displayed weak ectopic expres-
sion of 14-3-3s in the basal layer (Figures 4L and 4M). This differ-
ence was more pronounced at E16.5, when 14-3-3s was
strongly expressed in suprabasal cells but absent from the basal
layer in controls, and DcKO mutants displayed strong ectopic
14-3-3s expression in basal cells (Figures 4N and 4O). Similarly,
p21 was weakly expressed in control basal cells at E14.5 and
E16.5 and displayed increased immunoreactivity in mutant
epidermis (Figures 4P–4S).
The Ink4a/Arf locus produces two independent proteins: p16/
INK4a, which specifically binds and inhibits the cyclin-depen-
dent kinases 4 and 6, preventing phosphorylation of the retino-
blastoma tumor suppressor protein; and p19/ARF, which stabi-
lizes p53. p63 has been reported to directly repress both p16/
Ink4a and p19/Arf (Su et al., 2009). However, ectodermal defects
in p63 null embryos, including proliferation, stratification, and812 Developmental Cell 19, 807–818, December 14, 2010 ª2010 Elshair follicle specification, are rescued to a greater extent by
concomitant deletion of p16/Ink4a than by loss of p19/Arf (Su
et al., 2009). Interestingly, expression of p19/ARF appeared
unaffected by Hdac1/2 mutation (Figures S4G–S4J). However,
p16/INK4a was dramatically overexpressed in DcKO embryos
at both E14.5 and E16.5 (Figures 4T–4W). These data indicate
that key repressive functions of DNp63, including suppression
of p16/Ink4a, require HDAC1/2.
To determine whether the requirement for HDAC1/2 inDNp63-
mediated repression is direct, we first asked whether HDAC1/2
are present at the promoters of the 14-3-3s, p21 and p16/
INK4a genes in undifferentiated primary human epidermal kera-
tinocytes (HEKs). Chromatin immunoprecipitation (ChIP) assays
with antibodies to HDAC1 and HDAC2, and PCR primers that
amplify promoter regions containing p63-binding sites for each
of these genes, revealed specific binding of both HDAC1 and
HDAC2 in each case (Figure 4X, left panels). We next wanted
to determine whether HDACs are required for histone acetylation
at these promoter regions. To address this question we carried
out ChIP assays using the same primers to amplify 14-3-3s, p21
and p16/INK4a promoter sequences, antibodies to H3K9Ac, and
extracts of keratinocytes that had been cultured with or without
the HDAC inhibitor TSA. These experiments revealed increased
histone acetylation at the 14-3-3s, p21 and p16/INK4a pro-
moters in TSA-treated compared with control-treated cells
(Figure 4X, right panels). Quantification of bound H3K9Ac levels
by real-time PCR coupled with ChIP revealed that the increases
in H3K9Ac at the p21, 14-3-3s, and p16INK4a promoter regions
were statistically significant (p < 0.05 for all TSA-treated samples
compared with control treated, except for 14-3-3s in samples
treated with TSA for 6 hr, for which p = 0.05) (Figure S4K). By
contrast, levels of acetylated histone H3 at the negative control
GAPDH promoter were not significantly increased in TSA-
treated compared with control-treated cells (Figure S4K). Thus,
HDACs are specifically active at DNp63-repressed promoters.
These data are consistent with a direct requirement for
HDAC1/2 in DNp63-mediated repression of cell cycle inhibitory
genes and suggest that proliferative, stratification, and ecto-
dermal appendage defects in Hdac1/2 null epidermis are due
at least in part to failure of DNp63-repressive functions.
HDAC1/2 Suppress P53 Hyperacetylation
in Embryonic Epidermis
P53 positively regulates several targets of p63 repression,
including 14-3-3s and p21 (el-Deiry et al., 1993; Hermeking
et al., 1997), which are ectopically or overexpressed in DcKO
epidermis. In addition, levels of PCNA, which is indirectly sup-
pressed by P53 (Saifudeen et al., 2002), and a P53-activated
direct target GADD45A (Rosemary Siafakas and Richardson,
2009), were respectively decreased and increased in DcKO
compared with control epidermis at E16.5 (Figures 5A–5H).
In vitro studies suggest that P53 activity is repressed in an
HDAC1-dependent manner through removal of acetylation
marks from its C-terminal lysine residues (Higashitsuji et al.,
2007; Ito et al., 2002; Tang et al., 2008). Therefore, we asked
whether acetylated P53 levels were increased in DcKO
epidermis in vivo. Immunofluorescence revealed marked
increases in the levels of p53 acetylated at either lysine 379 or
lysine 386 in DcKO compared with control littermate epidermisevier Inc.
Figure 4. Hdac1 and Hdac2 Are Required for Repression of Negatively Regulated DNP63 Target Genes
(A) Immunofluorescence with pan-p63 antibody (green) reveals expression in the basal layer of littermate controls and in the single-layered DcKO epidermis at
E14.5, E16.5, and E18.5 (arrows).
(B–E) Expression of DNP63 (B and C, arrows) and undetectable expression of TAP63 (D and E) in both control (B and D) and DcKO (C and E) epidermis at E14.5.
(F–K) Positively regulated p63 targets FASN (F and G) (green), CDC25c (H and I) (brown), and claudin1 (J and K) (green) are similarly expressed in single-layered
DcKO (G, I, and K) and basal control (F, H, and J) epidermis (arrows).
(L–O) Immunofluorescence for 14-3-3s at E14.5 (L and M) (green signal) and E16.5 (N and O) (red signal) reveals its expression in control suprabasal cells
(N, yellow arrow) and absence in control basal cells (N, white arrow). In DcKO skin, 14-3-3s is expressed in the single-layered epithelium at both E14.5 (M)
and E16.5 (O) (yellow arrow).
(P–S) p21 immunostaining (brown) is slightly more intense in DcKO (Q and S) compared with control basal epidermis (P and R) at both E14.5 (P and Q) and E16.5
(R and S) (arrows).
(T–W) p16/INK4a (brown immunostaining) is dramatically upregulated in DcKO (U and W) compared with control (T and V) epidermis at both E14.5 (T and U) and
E16.5 (V and W) (arrows). Dashed lines indicate dermal-epidermal boundaries.
(X) CHiP assays with extracts of untreated HEKs and HEKs treated with TSA for 6 or 12 hr, and antibodies to HDAC1, HDAC2, H3K9Ac, or rabbit IgG negative
control, as indicated. Primers amplifying sequences that encompass GAPDH-negative control promoter regions or p63-binding sites in the promoter regions of
the 14-3-3s, p21, and p16/INK4a genes were used for PCR as indicated.
All panels in (A) were photographed at the same magnification; scale bar in (E) applies to (B)–(E); scale bars in (G), (I), (K), (M), and(O) also apply to their respective
littermate controls; and scale bar in (W) applies to (P)–(W).
See also Figure S4 and Table S1.
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Hdac1/2 Are Required for Epidermal Developmentat both E14.5 and E16.5 (Figures 5I–5P). Thus, Hdac1/2 are
necessary to suppress hyper-acetylation of P53 in embryonic
epidermis, and lack of this activity may contribute to upregula-
tion of cell cycle inhibitory genes and the observed proliferative
defects and apoptosis in DcKO embryos.Developmep53 Is Required for Upregulation of p21 in Keratinocytes
in Response to HDAC Inhibition
To test more directly whether increased levels of acetylated p53
might be required for the observed upregulation of epidermal
p21, we inhibited HDAC function in HEKs by treatment withntal Cell 19, 807–818, December 14, 2010 ª2010 Elsevier Inc. 813
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Figure 5. HDAC1/2 Suppress Hyper-Acetylation of p53 in Embryonic Epidermis
(A–D) PCNA (green) is expressed in control basal cell and some suprabasal cell nuclei at E14.5 (A) and E16.5 (C, arrows). PCNA is expressed in DcKO epidermis at
E14.5 (B) but is downregulated by E16.5 (D).
(E–H) GADD45A (green) is expressed in control suprabasal, but not basal cells at E14.5 (E) and E16.5 (G). In single-layered DcKO epidermis, GADD45A is weakly
expressed at E14.5 (F) and gives a strong signal at E16.5 (H, arrows).
(I–P) p53-AcK379 (I–L) and p53-AcK386 (M–P) (green) are undetectable in control basal nuclei at E14.5 (I and M) or E16.5 (K and O) and are weakly detected in
a subset of differentiating nuclei at E16.5 (K and O). DcKO epidermis displays strong staining for acetylated p53-AcK379 (J and L) and p53-AcK386 (N and P) at
both E14.5 (J and N) and E16.5 (L and P) (arrows). Dashed lines indicate dermal-epidermal junctions. Scale bars represent 25 mm.
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Hdac1/2 Are Required for Epidermal DevelopmentTSA. Twenty-four hours of TSA treatment resulted in a statisti-
cally significant decrease in proliferation (Figures 6A, 6D, and
6G; Figure S5C) as well as dramatic increases in the intensity
of immunofluorescence for acetylated p53 and for p21 (Figures
6B, 6C, 6E, and 6F). shRNA-mediated knockdown of p53 or
p21 expression resulted in reduced immunostaining for the cor-
responding protein (Figures 6H, 6I, 6K, and 6L), decreased tran-
script levels to approximately 25% of those observed in control
knockdown cells (Figures S5A and S5B), and inhibition of the
anti-proliferative effects of TSA (Figures 6G; Figure S5C). Knock-
down of p21 in TSA-treated cells did not affect total p53 levels
(Figures 6H and 6J). By contrast, knockdown of p53 prevented
accumulation of p21 protein andmRNA in response to TSA treat-
ment (Figures 6K, 6M, and 6N). Thus, p53 is required for elevated
p21 levels in response to HDAC inhibition in keratinocytes.
These data are consistent with a model in which increased
levels of p53 activity contribute to proliferative defects in
Hdac1/2-deficient epidermis. However, the relatively mild
effects of loss of Hdac1/2 on expression of p21 in DcKO
mutants, compared with dramatic upregulation of the p53-inde-
pendent gene p16/Ink4a by E14.5 (Figures 4P–4W), indicate that
p53-independent loss of DNP63 repressor functions plays
a major role. Although deletion of HDAC1/2 should immediately
relieve DNp63-mediated repression of p16/Ink4a, accumulation
of critical levels of acetylated p53 is likely required for increased
p53 activity and p53-mediated target gene activation. This less814 Developmental Cell 19, 807–818, December 14, 2010 ª2010 Elsdirect mechanism (Figure 6O) may account in part for our obser-
vation that activation of some p53 targets is delayed relative to
the increase in p16/INK4a expression. Because p53 is well
established as a pro-apoptotic protein, this indirect mechanism
may also explain the relatively late increase in apoptosis
observed in Hdac1/2 epidermal mutants (Figures 3E and 3G).
DISCUSSION
Here, we show that Hdac1/2 perform essential functions in ecto-
dermal appendage and epidermal development and are required
for basal epidermal cells to acquire suprabasal or hair follicle pla-
code fates. Consistent with specific defects resulting from
Hdac1/2 deletion in other tissues, KRT14-Cre-mediated loss of
Hdac1/2 produced an epidermal phenotype strikingly similar to
that of embryos lacking the epidermal master regulator, p63.
Krt14 is a direct, positively regulated p63 target (Romano et al.,
2009), and KRT14-Cre-mediated deletion of Hdac1/2 occurs
after initiation of p63 expression, but prior to development of
a suprabasal epidermal layer or specification of hair follicles
(Liu et al., 2007). In line with this, both p63 and KRT14 were
expressed in Hdac1/2 epidermal mutants, and defects in mor-
phogenesis of the limbs and ectodermal appendages such as
mammary glands, vibrissae, and teeth that develop before onset
of high levels ofKRT14-Cre expression were less severe than the
epidermal stratification and hair follicle phenotypes.evier Inc.
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Figure 6. p53 Is Required for Elevated p21
Expression in Response to HDAC Inhibition
in Keratinocytes
(A–F) TSA treatment of HEKs causes decreased
proliferation and increased expression of acety-
lated p53 and p21. HEKs treated with 500 nM
TSA in DMSO (D–F) or DMSO alone (A–C) were
subjected to immunofluorescence (green) using
antibodies to PH3 (A and D), p53-AcK379 (B and
E), or p21 (C and F).
(G) The TSA-induced decrease in proliferation
requires p53 and p21. HEKs were transduced
with retroviruses carrying control knockdown
(KD), p53 KD, or p21 KD shRNAmir constructs as
indicated and treated with 50 nm TSA in DMSO
(light-gray bars) or DMSO only (dark-gray bars).
The percentage of PH3-positive nuclei is indicated
for each condition. Ten fields of viewwere counted
per sample at 403 magnification, and the experi-
ment was performed in duplicate.
(H–N) p53 is required for the TSA-induced increase
in p21 expression. HEKs were transduced with
retroviruses carrying control (H and K), p53 (I and
M), or p21 (J and L) knockdown shRNAmirs and
treated with 50 nM TSA. Immunofluorescence
with antibodies to total p53 (H–J) (red) or p21
(K–M) (green) reveals efficient knockdown of p53
or p21 with the corresponding shRNAmir (H, I, K,
and L), and decreased p21 expression in p53
knockdown compared with control knockdown
cells (K and M). Knockdown of p21 does not affect
expression of p53 (H and J). (N) Quantification of
p21mRNA levels by real-timePCR reveals a statis-
tically significant increase in p21 mRNA expres-
sion in TSA-treated control knockdown cells
compared with DMSO-treated control knockdown
cells (dark-gray bars) (p < 0.05) and no TSA-
induced increase in p21 expression in either p21
(light- gray bars) or p53 (medium-gray bars) knock-
down cells.
(O) Model for interactions of HDAC1/2, DNp63,
and p53 in embryonic epidermis. DNp63 and
HDAC1/2 cooperate to directly repress expression
of p16/INK4a and may also directly contribute
to repression of p21. HDAC1/2 independently
deacetylate p53, suppressing its ability to induce
apoptosis andactivate target genes, includingp21.
Data in (G) and (N) are represented as mean
values; error bars represent SEM; asterisks indi-
cate statistical significance; NS, not statistically
significant.
See also Figure S5.
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Hdac1/2 Are Required for Epidermal DevelopmentConsistent with HDAC1/2’s functions in gene repression, we
found that, whereas p63-activated basal layer genes were unaf-
fected byHdac1/2 deletion, p63-suppressed genes, in particular
p16/Ink4a, were markedly dysregulated. We further showed that
HDAC1/2 bind the promoter regions of p63-repressed genes in
undifferentiated keratinocytes and that histone acetylation is
specifically increased in these regions following treatment with
the HDAC inhibitor TSA. Together, these results indicate that
HDAC1/2 directly mediate p63’s repressive functions. Loss of
the repressive functions of this key epidermal factor in Hdac1/
2mutants may mask other less central roles of Hdac1/2 at early
stages of epidermal development, accounting for the strikingDevelopmesimilarity of p63 null and Hdac1/2 mutant phenotypes.
HDAC1/2 are likely to play additional roles at subsequent embry-
onic stages and in adult skin and hair follicles. These may be
revealed by inducible epidermal-specific deletion of Hdac1/2
later in embryonic or postnatal life.
Interestingly, concomitant loss of p16/Ink4a partially rescues
multiple defects in p63 null epidermis, including progenitor cell
proliferation, stratification, and hair follicle development (Su
et al., 2009). Suppression of p16/INK4a expression is essential
for self-renewal of multiple types of progenitor cells (Akala
et al., 2008; Molofsky et al., 2006; Nishino et al., 2008). The
partial rescue of stratification and hair follicle defects in p63/ntal Cell 19, 807–818, December 14, 2010 ª2010 Elsevier Inc. 815
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Hdac1/2 Are Required for Epidermal Developmentp16/Ink4a/ double mutants suggests that this suppression is
also essential for asymmetric cell division and cell fate decisions
in embryonic epidermis. These data further suggest that the
dramatic increase in p16/INK4a levels in Hdac1/2 mutant
epidermis contributes in a major way to the observed defects
in epidermal development and hair follicle specification.
Asmentioned above, the defects inHdac1/2mutant epidermis
were remarkably similar to those described for p63 null skin.
However, one difference was that p19/ARF is upregulated in
p63 mutants, but its levels were not substantially altered by
Hdac1/2 deletion. We discovered that HDAC1/2 are required
to suppress hyper-acetylation of p53 in embryonic epidermis.
Because p53 indirectly suppresses levels of p19/ARF (Kamijo
et al., 1998; Stott et al., 1998), the competing effects of loss of
p63-mediated repression and increased p53 activity may
account for the relatively unchanged levels of p19/ARF in
Hdac1/2 compared with control epidermis. In addition to its
possible contribution to regulation of p19/ARF, experiments in
keratinocytes demonstrated that p53 is required for elevated
p21 expression in response to HDAC inhibition. Thus, it is likely
that hyper-acetylated p53 contributed to the observed upregula-
tion of p21 and proliferative defects in Hdac1/2 mutant
epidermis.
Loss of Hdac1/2 function in embryonic epidermis led to
a gradual decrease in proliferation rates relative to controls
and initially was not associated with increased apoptosis,
suggesting that, as in p63 null ectoderm (Senoo et al., 2007),
failure of basal progenitor cell self-renewal contributes to the
phenotype. Loss of either the epidermal histone methylase
EZH2 or the DNA methyltransferase DNMT1 also results in
defects in progenitor cell proliferation (Ezhkova et al., 2009;
Sen et al., 2010). Epidermis lacking Ezh2 displays increased
p16/INK4a expression (Ezhkova et al., 2009), consistent with
association of HDAC1/2 and EZH2 in the polycomb repressor
complex PRC2 (van der Vlag and Otte, 1999). However,
perhaps due to compensating activity of the related gene
Ezh1, Ezh2-deficient epidermis displays a much less severe
phenotype than that caused by loss of p63 or Hdac1/2 and
is capable of stratifying and producing a functional barrier
(Ezhkova et al., 2009).
Notably, unlike the effects of Hdac1/2 deletion or absence of
p63, loss of Ezh2 or DNMT1 is associated with premature differ-
entiation of basal cells (Ezhkova et al., 2009; Sen et al., 2010).
Thus, it is possible that Hdac1/2 control progenitor cell differen-
tiation in part throughmechanisms distinct from those utilized by
Ezh2 and DNMT1. Alternatively, persistence of methylation
marks in Hdac1/2 mutants might block precocious activation
of differentiation genes.
Unlike loss of EZH2 and DNMT1, lack of epidermal Mi-2b,
which associates with HDAC1/2 in the NuRD complex, does
not result in inappropriate activation of differentiation genes;
instead, differentiation markers are expressed appropriately,
and the epidermis stratifies normally. However, as in Hdac1/2-
deficient epidermis,Mi-2bmutants display defects in hair follicle
specification and a gradual decline in basal cell proliferation
(Kashiwagi et al., 2007). These common phenotypes may reflect
functions of the NuRD complex in hair follicle induction and
progenitor cell self-renewal. Precisely how HDAC1/2 and p63
interact with Mi-2b, EZH1/2, DNMT1, and other chromatin modi-816 Developmental Cell 19, 807–818, December 14, 2010 ª2010 Elsfication factors to coordinate gene expression in the developing
epidermis will be a fascinating area for further study.
In summary, our data reveal essential roles for Hdac1/2 in
proliferation, stratification, and cell fate decisions in the embry-
onic epidermis. Our results further suggest that Hdac1/2 are
required for mediating the repressive functions of p63 and for
suppressing p53 activity. Because increased expression of
HDACs in squamous cell carcinoma (SCC) predicts poor
outcome, and HDACi can induce growth arrest in SCC lines as
well as in normal keratinocytes, HDACs likely play key roles in
SCC as well as in epidermal morphogenesis (Chang et al.,
2009; Prystowsky et al., 2009; Saunders et al., 1999). Loss of
Hdac1/2 function results in derepression of cell cycle inhibitory
and senescence factors in embryonic basal cells, suggesting
specific targeting of these factors in undifferentiated epidermal
tumors as a potentially powerful therapeutic tool. Determining
the effects of Hdac1/2 deletion in adult epidermis and in skin
tumor models will be critically important in further testing the
utility of this approach.
EXPERIMENTAL PROCEDURES
Generation of Mice
Mice carrying Hdac1 and Hdac2 floxed alleles (Montgomery et al., 2007) were
crossed with transgenic KRT14-Cre line 43 mice (Andl et al., 2004). Genotyp-
ingwas as described previously (Andl et al., 2004;Montgomery et al., 2007). All
experiments were performed with approved animal protocols according to
institutional guidelines established by the University of Pennsylvania IUCAC
committee.
Histology, Immunostaining, and In Situ Hybridization
Histology, immunostaining, and whole mount in situ hybridization were carried
out as described previously (Zhang et al., 2009). Details of the antibodies used
are provided in Supplemental Experimental Procedures.
ChIP
ChIPwas carried out according to themanufacturer’s instructions using the EZ
ChIP kit (Millipore) or the Magnify CHiP System (Invitrogen) and extracts of
neonatal foreskin HEKs cultured in low-calcium medium (Li et al., 2005). For
analyses of bound H3K9Ac, HEKs were cultured in 0 nM or 500 nM TSA in
DMSO for 6 or 12 hr. Cells were fixed in 1% formaldehyde, lysed, and chro-
matin was sheared using a Bioruptor UCD-200 (Diagenode) to 200 base
pair fragments. Chromatin was immunoprecipitated with antibodies to
HDAC1 (Abcam), HDAC2 (Abcam), H3K9Ac (Abcam), or Rabbit IgG (Millipore).
Real-time PCR experiments coupled with ChIP utilized the StepOnePlus
system and software (Applied Biosystems) and SYBR Green reagents (DNA
Master). Changes were determined based on the 2D DCT method. See Table
S1 for PCR primer sequences.
Assays for Proliferation and P53-AcK379 Expression in HEKs
Neonatal foreskin HEKs in low-calcium medium (Li et al., 2005) were plated at
20% confluency, treated with either 500 nM TSA in DMSO or DMSO alone for
24 hr, fixed with 4% paraformaldehyde, and immunostained with antibodies to
PH3 (1:200) (Millipore) or P53-AcK379 (1:200) (Abcam).
shRNAmir Knockdown Experiments
Neonatal foreskin HEKs were transduced with retroviruses carrying shRNAmir
nonsilencing, p53, or p21 vectors (OpenBiosystems RHS4971, RHS4917-
99781715, and RHS4917-99780100, respectively). Following puromycin
selection, cells were treated with control (DMSO) or 50 nM TSA in DMSO for
24 hr, fixed, permeabilized, and immunostained with anti-PH3 (Millipore),
p21 (Abcam), p53 (Abcam), or P53-AcK379 (Abcam). Each experimental
condition was performed in duplicate, and the entire experiment was carried
out twice. Detailed methods are provided in Supplemental Experimental
Procedures.evier Inc.
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Hdac1/2 Are Required for Epidermal DevelopmentQuantification of Transcript Levels by Real-Time PCR
Total RNA was purified using an RNeasy kit (QIAGEN), reverse-transcribed
using First-Strand cDNA Synthesis Kit (GE, Amersham), and subjected to
real-time PCR using the StepOnePlus system and software (Applied Biosys-
tems) and SYBR Green reagents (DNA Master). See Supplemental Experi-
mental Procedures for detailed methods and primer sequences.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and one table and can be found with this article online at doi:
10.1016/j.devcel.2010.10.015.
ACKNOWLEDGMENTS
We thank L. Ash and T. Dentchev for histology, N. Sarikonda for technical
assistance, and members of the S.E.M., E.E.M., and J.A.E. labs for helpful
discussions. Research in S.E.M.’s lab is supported by RO1AR47709,
RO1HD053829, RO1AR055241, and RC1DE020337. M.L. was supported by
T32AR007465 and T32HD007516. J.A.E. and E.E.M. received support from
UO1HL100405, and J.A.E. was supported by RO1HL071546.
Received: August 24, 2010
Revised: October 26, 2010
Accepted: October 26, 2010
Published online: November 18, 2010
REFERENCES
Akala, O.O., Park, I.K., Qian, D., Pihalja, M., Becker, M.W., and Clarke, M.F.
(2008). Long-term haematopoietic reconstitution by Trp53/p16Ink4a/
p19Arf/ multipotent progenitors. Nature 453, 228–232.
Andl, T., Ahn, K., Kairo, A., Chu, E.Y., Wine-Lee, L., Reddy, S.T., Croft, N.J.,
Cebra-Thomas, J.A., Metzger, D., Chambon, P., et al. (2004). Epithelial
Bmpr1a regulates differentiation and proliferation in postnatal hair follicles
and is essential for tooth development. Development 131, 2257–2268.
Blanpain, C., and Fuchs, E. (2007). p63: revving up epithelial stem-cell poten-
tial. Nat. Cell Biol. 9, 731–733.
Brunmeir, R., Lagger, S., and Seiser, C. (2009). Histone deacetylase HDAC1/
HDAC2-controlled embryonic development and cell differentiation. Int. J. Dev.
Biol. 53, 275–289.
Byrne, C., Tainsky, M., and Fuchs, E. (1994). Programming gene expression in
developing epidermis. Development 120, 2369–2383.
Candi, E., Terrinoni, A., Rufini, A., Chikh, A., Lena, A.M., Suzuki, Y., Sayan,
B.S., Knight, R.A., and Melino, G. (2006). p63 is upstream of IKK alpha in
epidermal development. J. Cell Sci. 119, 4617–4622.
Chang, H.H., Chiang, C.P., Hung, H.C., Lin, C.Y., Deng, Y.T., and Kuo, M.Y.
(2009). Histone deacetylase 2 expression predicts poorer prognosis in oral
cancer patients. Oral Oncol. 45, 610–614.
Chikh, A., Sayan, E., Thibaut, S., Lena, A.M., DiGiorgi, S., Bernard, B.A.,
Melino, G., and Candi, E. (2007). Expression of GATA-3 in epidermis and
hair follicle: relationship to p63. Biochem. Biophys. Res. Commun. 361, 1–6.
el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent,
J.M., Lin, D., Mercer, W.E., Kinzler, K.W., and Vogelstein, B. (1993). WAF1,
a potential mediator of p53 tumor suppression. Cell 75, 817–825.
Ezhkova, E., Pasolli, H.A., Parker, J.S., Stokes, N., Su, I.H., Hannon, G.,
Tarakhovsky, A., and Fuchs, E. (2009). Ezh2 orchestrates gene expression
for the stepwise differentiation of tissue-specific stem cells. Cell 136, 1122–
1135.
Frye, M., Fisher, A.G., and Watt, F.M. (2007). Epidermal stem cells are defined
by global histone modifications that are altered by Myc-induced differentia-
tion. PLoS ONE 2, e763.
Haberland, M., Montgomery, R.L., and Olson, E.N. (2009). The many roles of
histone deacetylases in development and physiology: implications for disease
and therapy. Nat. Rev. Genet. 10, 32–42.DevelopmeHermeking, H., Lengauer, C., Polyak, K., He, T.C., Zhang, L., Thiagalingam, S.,
Kinzler, K.W., and Vogelstein, B. (1997). 14-3-3 sigma is a p53-regulated
inhibitor of G2/M progression. Mol. Cell 1, 3–11.
Higashitsuji, H., Masuda, T., Liu, Y., Itoh, K., and Fujita, J. (2007). Enhanced
deacetylation of p53 by the anti-apoptotic protein HSCO in association with
histone deacetylase 1. J. Biol. Chem. 282, 13716–13725.
Indra, A.K., Dupe, V., Bornert, J.M., Messaddeq, N., Yaniv, M., Mark, M.,
Chambon, P., and Metzger, D. (2005). Temporally controlled targeted somatic
mutagenesis in embryonic surface ectodermand fetal epidermal keratinocytes
unveils two distinct developmental functions of BRG1 in limb morphogenesis
and skin barrier formation. Development 132, 4533–4544.
Ingraham, C.R., Kinoshita, A., Kondo, S., Yang, B., Sajan, S., Trout, K.J., Malik,
M.I., Dunnwald, M., Goudy, S.L., Lovett, M., et al. (2006). Abnormal skin, limb
and craniofacial morphogenesis in mice deficient for interferon regulatory
factor 6 (Irf6). Nat. Genet. 38, 1335–1340.
Ito, A., Kawaguchi, Y., Lai, C.H., Kovacs, J.J., Higashimoto, Y., Appella, E., and
Yao, T.P. (2002). MDM2-HDAC1-mediated deacetylation of p53 is required for
its degradation. EMBO J. 21, 6236–6245.
Jamora, C., DasGupta, R., Kocieniewski, P., and Fuchs, E. (2003). Links
between signal transduction, transcription and adhesion in epithelial bud
development. Nature 422, 317–322.
Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F., and Sherr, C.J.
(1998). Functional and physical interactions of the ARF tumor suppressor with
p53 and Mdm2. Proc. Natl. Acad. Sci. USA 95, 8292–8297.
Kashiwagi, M., Morgan, B.A., and Georgopoulos, K. (2007). The chromatin
remodeler Mi-2beta is required for establishment of the basal epidermis and
normal differentiation of its progeny. Development 134, 1571–1582.
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel,
A., Sawyer, A., Ikeda, T., et al. (1999). Ikaros DNA-binding proteins direct
formation of chromatin remodeling complexes in lymphocytes. Immunity 10,
345–355.
Koster, M.I. (2010). p63 in skin development and ectodermal dysplasias.
J. Invest. Dermatol. 130, 2352–2358.
Koster, M.I., Dai, D., Marinari, B., Sano, Y., Costanzo, A., Karin, M., and Roop,
D.R. (2007). p63 induces key target genes required for epidermal morphogen-
esis. Proc. Natl. Acad. Sci. USA 104, 3255–3260.
Laurikkala, J., Mikkola, M.L., James, M., Tummers, M., Mills, A.A., and
Thesleff, I. (2006). p63 regulatesmultiple signalling pathways required for ecto-
dermal organogenesis and differentiation. Development 133, 1553–1563.
Lechler, T., and Fuchs, E. (2005). Asymmetric cell divisions promote stratifica-
tion and differentiation of mammalian skin. Nature 437, 275–280.
Lefkimmiatis, K., Caratozzolo, M.F., Merlo, P., D’Erchia, A.M., Navarro, B.,
Levrero, M., Sbisa, E., and Tullo, A. (2009). p73 and p63 sustain cellular growth
by transcriptional activation of cell cycle progression genes. Cancer Res. 69,
8563–8571.
Li, W., Marshall, C., Mei, L., Dzubow, L., Schmults, C., Dans, M., and Seykora,
J. (2005). Srcasm modulates EGF and Src-kinase signaling in keratinocytes.
J. Biol. Chem. 280, 6036–6046.
Liu, F., Thirumangalathu, S., Gallant, N.M., Yang, S.H., Stoick-Cooper, C.L.,
Reddy, S.T., Andl, T., Taketo, M.M., Dlugosz, A.A., Moon, R.T., et al. (2007).
Wnt-beta-catenin signaling initiates taste papilla development. Nat. Genet.
39, 106–112.
Liu, F., Chu, E.Y., Watt, B., Zhang, Y., Gallant, N.M., Andl, T., Yang, S.H., Lu,
M.M., Piccolo, S., Schmidt-Ullrich, R., et al. (2008). Wnt/beta-catenin signaling
directs multiple stages of tooth morphogenesis. Dev. Biol. 313, 210–224.
Lopardo, T., Lo Iacono, N., Marinari, B., Giustizieri, M.L., Cyr, D.G., Merlo, G.,
Crosti, F., Costanzo, A., and Guerrini, L. (2008). Claudin-1 is a p63 target gene
with a crucial role in epithelial development. PLoS ONE 3, e2715.
Marinari, B., Ballaro, C., Koster, M.I., Giustizieri, M.L., Moretti, F., Crosti, F.,
Papoutsaki, M., Karin, M., Alema, S., Chimenti, S., et al. (2009). IKKalpha is
a p63 transcriptional target involved in the pathogenesis of ectodermal dyspla-
sias. J. Invest. Dermatol. 129, 60–69.
McDade, S.S., and McCance, D.J. (2010). The role of p63 in epidermal
morphogenesis and neoplasia. Biochem. Soc. Trans. 38, 223–228.ntal Cell 19, 807–818, December 14, 2010 ª2010 Elsevier Inc. 817
Developmental Cell
Hdac1/2 Are Required for Epidermal DevelopmentMikkola, M.L., andMillar, S.E. (2006). Themammary bud as a skin appendage:
unique and shared aspects of development. J. Mammary Gland Biol.
Neoplasia 11, 187–203.
Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R., and Bradley, A.
(1999). p63 is a p53 homologue required for limb and epidermal morphogen-
esis. Nature 398, 708–713.
Molofsky, A.V., Slutsky, S.G., Joseph, N.M., He, S., Pardal, R., Krishnamurthy,
J., Sharpless, N.E., andMorrison, S.J. (2006). Increasing p16INK4a expression
decreases forebrain progenitors and neurogenesis during ageing. Nature 443,
448–452.
Montgomery, R.L., Davis, C.A., Potthoff, M.J., Haberland, M., Fielitz, J., Qi, X.,
Hill, J.A., Richardson, J.A., and Olson, E.N. (2007). Histone deacetylases 1 and
2 redundantly regulate cardiac morphogenesis, growth, and contractility.
Genes Dev. 21, 1790–1802.
Nishino, J., Kim, I., Chada, K., and Morrison, S.J. (2008). Hmga2 promotes
neural stem cell self-renewal in young but not old mice by reducing
p16Ink4a and p19Arf Expression. Cell 135, 227–239.
Prystowsky, M.B., Adomako, A., Smith, R.V., Kawachi, N., McKimpson, W.,
Atadja, P., Chen, Q., Schlecht, N.F., Parish, J.L., Childs, G., et al. (2009).
The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes
causing G2/M arrest and cell death in head and neck squamous cell carcinoma
cell lines. J. Pathol. 218, 467–477.
Romano, R.A., Ortt, K., Birkaya, B., Smalley, K., and Sinha, S. (2009). An active
role of the DeltaN isoform of p63 in regulating basal keratin genes K5 and K14
and directing epidermal cell fate. PLoS ONE 4, e5623.
Rosemary Siafakas, A., and Richardson, D.R. (2009). Growth arrest and DNA
damage-45 alpha (GADD45alpha). Int. J. Biochem. Cell Biol. 41, 986–989.
Ruthenburg, A.J., Li, H., Patel, D.J., and Allis, C.D. (2007). Multivalent engage-
ment of chromatin modifications by linked binding modules. Nat. Rev. Mol.
Cell Biol. 8, 983–994.
Saifudeen, Z., Marks, J., Du, H., and El-Dahr, S.S. (2002). Spatial repression of
PCNA by p53 during kidney development. Am. J. Physiol. Renal Physiol. 283,
F727–F733.
Saunders, N., Dicker, A., Popa, C., Jones, S., and Dahler, A. (1999). Histone
deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res. 59,
399–404.818 Developmental Cell 19, 807–818, December 14, 2010 ª2010 ElsSen, G.L., Reuter, J.A., Webster, D.E., Zhu, L., and Khavari, P.A. (2010).
DNMT1 maintains progenitor function in self-renewing somatic tissue.
Nature 463, 563–567.
Senoo, M., Pinto, F., Crum, C.P., and McKeon, F. (2007). p63 Is essential for
the proliferative potential of stem cells in stratified epithelia. Cell 129, 523–536.
Stott, F.J., Bates, S., James, M.C., McConnell, B.B., Starborg, M., Brookes,
S., Palmero, I., Ryan, K., Hara, E., Vousden, K.H., et al. (1998). The alternative
product from the human CDKN2A locus, p14(ARF), participates in a regulatory
feedback loop with p53 and MDM2. EMBO J. 17, 5001–5014.
Su, X., Cho, M.S., Gi, Y.J., Ayanga, B.A., Sherr, C.J., and Flores, E.R. (2009).
Rescue of key features of the p63-null epithelial phenotype by inactivation of
Ink4a and Arf. EMBO J. 28, 1904–1915.
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., and Gu, W. (2008). Acetylation is indis-
pensable for p53 activation. Cell 133, 612–626.
Truong, A.B., and Khavari, P.A. (2007). Control of keratinocyte proliferation and
differentiation by p63. Cell Cycle 6, 295–299.
Truong, A.B., Kretz, M., Ridky, T.W., Kimmel, R., and Khavari, P.A. (2006). p63
regulates proliferation and differentiation of developmentally mature keratino-
cytes. Genes Dev. 20, 3185–3197.
van der Vlag, J., and Otte, A.P. (1999). Transcriptional repression mediated by
the human polycomb-group protein EED involves histone deacetylation. Nat.
Genet. 23, 474–478.
Westfall, M.D., Mays, D.J., Sniezek, J.C., and Pietenpol, J.A. (2003). The Delta
Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo
and has transcriptional repressor activity that is reduced by Hay-Wells
syndrome-derived mutations. Mol. Cell. Biol. 23, 2264–2276.
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R.T.,
Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999). p63 is essential for
regenerative proliferation in limb, craniofacial and epithelial development.
Nature 398, 714–718.
Zhang, Y., Tomann, P., Andl, T., Gallant, N.M., Huelsken, J., Jerchow, B.,
Birchmeier, W., Paus, R., Piccolo, S., Mikkola, M.L., et al. (2009). Reciprocal
requirements for EDA/EDAR/NF-kappaB and Wnt/beta-catenin signaling
pathways in hair follicle induction. Dev. Cell 17, 49–61.evier Inc.
